Completed
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
NCT00492258
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Royal Bournemouth Hospital Bournemouth, England, United Kingdom
- Bristol Haematology and Oncology Centre Bristol, England, United Kingdom
- Queen's Hospital Burton-on-Trent, England, United Kingdom
- Addenbrooke's Hospital Cambridge, England, United Kingdom